- Home
- PRA vs PHAR Comparison
PRA vs PHAR Comparison
Compare PRA & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRA | PHAR |
|---|---|---|
| Founded | 1976 | 1988 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2000 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PRA | PHAR |
|---|---|---|
| Price | $24.50 | $15.16 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $25.00 | ★ $38.00 |
| AVG Volume (30 Days) | ★ 572.3K | 19.0K |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.99 | N/A |
| Revenue | ★ $1,098,028,000.00 | N/A |
| Revenue This Year | N/A | $27.92 |
| Revenue Next Year | N/A | $8.86 |
| P/E Ratio | ★ $24.78 | $3,041.22 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.30 | $7.50 |
| 52 Week High | $24.77 | $21.34 |
Technical Indicators
Market Signals| Indicator | PRA | PHAR |
|---|---|---|
| Relative Strength Index (RSI) | 51.25 | 41.57 |
| Support Level | $23.88 | $12.98 |
| Resistance Level | $24.64 | $16.94 |
| Average True Range (ATR) | 0.12 | 0.65 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 28.00 | 12.17 |
Price Performance
Historical ComparisonAbout PRA ProAssurance Corporation
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.